Skip to Main Content
Directory of Faculty Research Interests
YSM Home

INFORMATION FOR

DownloadHi-Res Photo

Richard Antaya, MD

Professor of Dermatology; Director, Pediatric Dermatology; Medical Director, Yale Dermatology New Haven, Dermatology

Contact Information

Richard Antaya, MD

Mailing Address

  • Dermatology

    PO Box 208059, 333 Cedar Street

    New Haven, CT 06520-8059

    United States

Infantile Hemangiomas
Download CV
Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

Pediatric Dermatology: specializes in the diagnosis and management of all types of skin disease affecting infants, children and adolescents. Besides treating common skin disorders in children such as atopic dermatitis, psoriasis, cutaneous infections and acne, particular interests include genetic skin disorders, neonatal skin disease, medical and laser treatment of vascular malformations and hemangiomas, management dilemmas and severe skin disease affecting children of all ages.

Specialized terms: Atopic dermatitis; Infantile hemangiomas; Warts; Genetic skin diseases

Extensive Research Description

Pediatric Dermatology: specializes in the diagnosis and management of all types of skin disease affecting infants, children and adolescents. Besides treating common skin disorders in children such as atopic dermatitis, psoriasis, cutaneous infections and acne, particular interests include genetic skin disorders, neonatal skin disease, medical and laser treatment of vascular malformations and hemangiomas, management dilemmas and severe skin disease affecting children of all ages.

  • Dr. Antaya is conducting a clinical trial for adolescents who have severe atopic dermatitis using a new biologic medication.
  • Dr. Antaya is conducting a clinical trial for children who have experienced chilblains over the last 5 years.


Coauthors

Research Interests

Acne Vulgaris; Dermatitis, Atopic; Dermatology; Hemangioma; Pediatrics; Skin Diseases, Genetic; Warts; Vascular Malformations

Selected Publications

  • 399 Tralokinumab treatment modifies stratum corneum lipid composition in skin of adolescents with atopic dermatitisBerdyshev E, Simpson E, Bronova I, Pavel A, Soong W, Antaya R, Imafuku S, Røpke M, Jiang L, Guttman-Yassky E, Leung D. 399 Tralokinumab treatment modifies stratum corneum lipid composition in skin of adolescents with atopic dermatitis Journal Of Investigative Dermatology 2022, 142: s68. DOI: 10.1016/j.jid.2022.05.408.
  • Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disordersAtzmony L, Ugwu N, Hamilton C, Paller A, Zech L, Antaya R, Choate K. Inflammatory linear verrucous epidermal nevus (ILVEN) encompasses a spectrum of inflammatory mosaic disorders Pediatric Dermatology 2022, 39: 903-907. PMID: 35853659, PMCID: PMC9712156, DOI: 10.1111/pde.15094.
  • Toxic epidermal necrolysis‐like acute graft‐versus‐host disease in pediatric bone marrow transplant patients: Case series and review of the literatureSong J, Huang JT, del Carmen Fraile Alonso M, Antaya RJ, Price HN, Funk T, Francois RA, Shah SD. Toxic epidermal necrolysis‐like acute graft‐versus‐host disease in pediatric bone marrow transplant patients: Case series and review of the literature Pediatric Dermatology 2022, 39: 889-895. PMID: 35730149, DOI: 10.1111/pde.15069.
  • Chronic Retiform Purpura of the Abdomen and Thighs: A Fatal Case of Intravascular Large Cell Lymphoma.Ugwu N, Kibbi N, Perincheri S, Antaya RJ. Chronic Retiform Purpura of the Abdomen and Thighs: A Fatal Case of Intravascular Large Cell Lymphoma. Cutis 2022, 109: e12-e14. PMID: 35960983, DOI: 10.12788/cutis.0552.
  • Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense VariantsMosallaei D, Hao M, Antaya RJ, Levian B, Kwong A, Cogan J, Hamilton C, Schwieger-Briel A, Tan C, Tang X, Woodley DT, Chen M. Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants JAMA Dermatology 2022, 158: 366-374. PMID: 35234826, PMCID: PMC8892363, DOI: 10.1001/jamadermatol.2021.5992.
  • Topical sirolimus therapy for nevus sebaceus and epidermal nevus: a case seriesZhou AG, Antaya RJ. Topical sirolimus therapy for nevus sebaceus and epidermal nevus: a case series Journal Of The American Academy Of Dermatology 2021, 87: 407-409. PMID: 34428533, DOI: 10.1016/j.jaad.2021.08.029.
  • 861 Intravenous gentamicin therapy for junctional epidermolysis bullosa patients harboring nonsense mutationsHao M, Antaya R, Cogan J, Hamilton C, Hou Y, Kwong A, Woodley D, Chen M. 861 Intravenous gentamicin therapy for junctional epidermolysis bullosa patients harboring nonsense mutations Journal Of Investigative Dermatology 2020, 140: s112. DOI: 10.1016/j.jid.2020.03.877.
  • Perinasal and Perioral Rash in a 2-Year-Old GirlTintle S, Antaya R, Halasz C. Perinasal and Perioral Rash in a 2-Year-Old Girl 2016, 83-87. DOI: 10.1542/9781610020176-part04-ch016.
  • Linear acral lesions in an infantMcNiff J, Kim J, Antaya R. Linear acral lesions in an infant Journal Of The American Academy Of Dermatology 2010, 63: e67-e68. DOI: 10.1016/j.jaad.2009.08.019.
  • 25 Enfermedades neoplásicas e infiltrativasProse N, Antaya R. 25 Enfermedades neoplásicas e infiltrativas 2009, 461-476. DOI: 10.1016/b978-84-8086-390-2.50025-5.
  • ColaboradoresAntaya R, Baselga E, Bernard L, Bradley J, Bree A, Bruckner A, Burkhart C, Carder K, Chan Y, Chu D, Cohen B, Cunningham B, Dinulos J, Drolet B, Enjolras O, Friedlander S, Galbraith S, Garzon M, Gibbs N, Gilliam A, Hebert A, Honig P, Howard R, Irvine A, Kim H, Kos L, Koss T, Krafchik B, Krol A, Lawley L, Levy M, Loomis C, Lucky A, Makkar H, Mancini A, Metry D, Metz B, Morrell D, Pace N, Paller A, Prendiville J, Prose N, Rogers M, Siegel D, Siegfried E, Silverman R, Tay Y, Torrelo A, Wagner A, Williams M, Wong L, Yan A. Colaboradores 2009, xi-xiii. DOI: 10.1016/b978-84-8086-390-2.50033-4.
  • Pediatric dermatology workforce shortage: Perspectives from academiaCraiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. Pediatric dermatology workforce shortage: Perspectives from academia Journal Of The American Academy Of Dermatology 2008, 59: 986-989. PMID: 18835061, DOI: 10.1016/j.jaad.2008.08.036.
  • PsoriasisHinds G, Antaya R. Psoriasis 2008, 2447-2454. DOI: 10.1542/9781581106411-9-ch314.
  • Educating Adolescents About Acne Vulgaris: A Comparison of Written Handouts With Audiovisual Computerized PresentationsKoch PE, Ryder HF, Dziura J, Njike V, Antaya RJ. Educating Adolescents About Acne Vulgaris: A Comparison of Written Handouts With Audiovisual Computerized Presentations JAMA Dermatology 2008, 144: 208-214. PMID: 18283177, DOI: 10.1001/archdermatol.2007.35.
  • Chapter 25 Neoplastic and Infiltrative DiseasesProse N, Antaya R. Chapter 25 Neoplastic and Infiltrative Diseases 2008, 461-476. DOI: 10.1016/b978-1-4160-3432-2.50028-5.
  • Topical vitamin E solution versus placebo in the treatment of yellow nail syndrome: a randomized double-blind study1 1Disclosure not available at press time.Lambert E, Antaya R. Topical vitamin E solution versus placebo in the treatment of yellow nail syndrome: a randomized double-blind study1 1Disclosure not available at press time. Journal Of The American Academy Of Dermatology 2004, 50: p130. DOI: 10.1016/j.jaad.2003.10.445.
Edit Profile